Evaluation of the predisposing factors and involved outcome of surgical treatment in bisphosphonate-related osteonecrosis of the jaw cases including bone biopsies

키워드

참고문헌 (45)

1. McClung MR, "Bisphosphonates", Endocrinol Metab Clin North Am, 32, pp.253~271 (2003)
2. Stanton DC, "Outcome of surgical management of bisphosphonate-related osteonecrosis of the jaws: review of 33 surgical cases", J Oral Maxillofac Surg, 67, pp.943~950 (2009)
3. Marx RE, "Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic", J Oral Maxillofac Surg, 61, pp.1115~1117 (2003)
4. Ruggiero SL, "Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases", J Oral Maxillofac Surg, 62, pp.527~534 (2004)
5. Hinson AM, "Is bisphosphonate-related osteonecrosis of the jaw an infection? A histological and microbiological ten-year summary", Int J Dent (2014)[DOI]
6. Ohe JY, "Bisphosphonates modulate the expression of OPG and M-CSF in hMSC-derived osteoblasts", Clin Oral Investig, 16, pp.1153~1159 (2012)
7. Kim RH, "Bisphosphonates induce senescence in normal human oral keratinocytes", J Dent Res, 90, pp.810~816 (2011)
8. Kos M, "Clinical comparison of patients with osteonecrosis of the jaws, with and without a history of bisphosphonates administration", Int J Oral Maxillofac Surg, 39, pp.1097~1102 (2010)
9. Lee SH, "Risk of osteonecrosis in patients taking bisphosphonates for prevention of osteoalsoa systematic review and meta-analysis", Osteoporos Int, 25, pp.1131~1139 (2014)
10. Khamaisi M, "Possible association between diabetes and bisphosphonaterelated jaw osteonecrosis", J Clin Endocrinol Metab, 92, pp.1172~1175 (2007)
11. Sung EC, "Osteonecrosis of the maxilla as a complication to chemotherapy: a case report", Spec Care Dentist, 22, pp.142~146 (2002)
12. Tarassoff P, "Avascular necrosis of the jaws: risk factors in metastatic cancer patients", J Oral Maxillofac Surg, 61, pp.1238~1239 (2003)
13. Migliorati CA, "Bisphosphonate-associated osteonecrosis of mandibular and maxillary bone: an emerging oral complication of supportive cancer therapy", Cancer, 104, pp.83~93 (2005)
14. Hewitt C, "Bisphosphonate-related osteonecrosis of the jaws: a comprehensive review", J Oral Pathol Med, 36, pp.319~328 (2007)
15. Leite AF, "Bisphosphonate-associated osteonecrosis of the jaws. Report of a case and literature review", Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 102, pp.14~21 (2006)
16. Marx RE, "Oral bisphosphonate-induced osteonecrosis:risk factors, prediction of risk using serum CTX testing, prevention, and treatment", J Oral Maxillofac Surg, 65, pp.2397~2410 (2007)
17. Freiberger JJ, "Hyperbaric oxygen treatment and bisphosphonateinduced osteonecrosis of the jaw: a case series", J Oral Maxillofac Surg, 65, pp.1321~1327 (2007)
18. Vescovi P, "Bisphosphonateassociated osteonecrosis (BON) of the jaws: a possible treatment?", J Oral Maxillofac Surg, 64, pp.1460~1462 (2006)
19. Lopes RN, "Surgical therapy for bisphosphonate-related osteonecrosis of the jaw:six-year experience of a single institution", J Oral Maxillofac Surg, 73, pp.1288~1295 (2015)
20. Stockmann P, "The outcome after surgical therapy of bisphosphonate-associated osteonecrosis of the jaw--results of a clinical case series with an average follow-up of 20 months", Clin Oral Investig, 18, pp.1299~1304 (2014)
21. Carlson ER, "The role of surgical resection in the management of bisphosphonate-related osteonecrosis of the jaws", J Oral Maxillofac Surg, 67(5 Suppl), pp.85~95 (2009)
22. Reich W, "Surgical treatment of bisphosphonate-associated osteonecrosis:Prognostic score and long-term results", J Craniomaxillofac Surg, 43, pp.1809~1822 (2015)
23. 김경욱, "비스포스포네이트 관련 악골괴사의 진단 및 치료에 대한 임상적 연구", 대한구강악안면외과학회지, 37(1), pp.54~61 (2011), 대한구강악안면외과학회
24. Lehenkari PP, "Further insight into mechanism of action of clodronate: inhibition of mitochondrial ADP", ATP translocase by a nonhydrolyzable, adenine-containing metabolite, 2002, pp.61, 1255~1262
25. Molcho S, "Diabetes microvascular disease and the risk for bisphosphonate-related osteonecrosis of the jaw: a single center study", J Clin Endocrinol Metab, 98, pp.E1807~1812 (2013)
26. Watters AL, "Intravenous bisphosphonate-related osteonecrosis of the jaw: long-term follow-up of 109 patients", Oral Surg Oral Med Oral Pathol Oral Radiol, 115, pp.192~200 (2013)
27. Favus MJ, "Diabetes and the risk of osteonecrosis of the jaw", J Clin Endocrinol Metab, 92, pp.817~818 (2007)
28. Ichiseki T, "Oxidative stress by glutathione depletion induces osteonecrosis in rats", Rheumatology (Oxford), 45, pp.287~290 (2006)
29. Ortega C, "Osteonecrosis of the jaw in prostate cancer patients with bone metastases treated with zoledronate: a retrospective analysis", Acta Oncol, 46, pp.664~668 (2007)
30. Vieillard MH, "Thirteen cases of jaw osteonecrosis in patients on bisphosphonate therapy", Joint Bone Spine, 75, pp.34~40 (2008)
31. Kos M, "Bisphosphonate-related osteonecrosis of the jaws: a review of 34 cases and evaluation of risk", J Craniomaxillofac Surg, 38, pp.255~259 (2010)
32. Brown JE, "Bone turnover markers as predictors of skeletal complications in prostate cancer, lung cancer, and other solid tumors", J Natl Cancer Inst, 97, pp.59~69 (2005)
33. Garnero P, "Noninvasive techniques for assessing skeletal changes in inflammatory arthritis: bone biomarkers", Curr Opin Rheumatol, 16, pp.428~434 (2004)
34. Fleisher KE, "Predicting risk for bisphosphonate-related osteonecrosis of the jaws: CTX versus radiographic markers", Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 110, pp.509~516 (2010)
35. Kunchur R, "Clinical investigation of C-terminal cross-linking telopeptide test in prevention and management of bisphosphonate-associated osteonecrosis of the jaws", J Oral Maxillofac Surg, 67, pp.1167~1173 (2009)
36. American Society for Bone and Mineral Research Task Force on Osteonecrosis of the Jaw, "Oral bisphosphonate-induced osteonecrosis:risk factors, prediction of risk using serum CTX testing, prevention, and treatment", J Oral Maxillofac Surg, 66, pp.1320~1321 (2008)
37. Berger CE, "Spontaneous osteonecrosis of the knee: biochemical markers of bone turnover and pathohistology", Osteoarthritis Cartilage, 13, pp.716~721 (2005)
38. Ganguli A, "Bacterial adhesion to bisphosphonate coated hydroxyapatite", J Mater Sci Mater Med, 16, pp.283~287 (2005)
39. Kos M, "Pamidronate enhances bacterial adhesion to bone hydroxyapatite. Another puzzle in the pathology of bisphosphonaterelated osteonecrosis of the jaw?", J Oral Maxillofac Surg, 71, pp.1010~1016 (2013)
40. Anavi-Lev K, "Bisphosphonate related osteonecrosis of the jaws: clinico-pathological investigation and histomorphometric analysis", Oral Surg Oral Med Oral Pathol Oral Radiol, 115, pp.660~666 (2013)
41. Hansen T, "Actinomycosis of the jaws--histopathological study of 45 patients shows significant involvement in bisphosphonate-associated osteonecrosis and infected osteoradionecrosis", Virchows Arch, 451, pp.1009~1017 (2007)
42. Naik NH, "Bisphosphonate-related osteonecrosis of the jaw: the role of actinomyces", Clin Infect Dis, 49, pp.1729~1732 (2009)
43. Kumar SK, "The role of microbial biofilms in osteonecrosis of the jaw associated with bisphosphonate therapy", Curr Osteoporos Rep, 8, pp.40~48 (2010)
44. Sedghizadeh PP, "Metagenomic investigation of microbes and viruses in patients with jaw osteonecrosis associated with bisphosphonate therapy", Oral Surg Oral Med Oral Pathol Oral Raporosisdiol, 114, pp.764~770 (2012)
45. Marx RE, "Suppurative osteomyelitis, bisphosphonate induced osteonecrosis, osteoradionecrosis: a blinded histopathologic comparison and its implications for the mechanism of each disease", Int J Oral Maxillofac Surg, 41, pp.283~289 (2012)

관련 논문AI추천